Maybe it feels like a band-aid instead of a real solution
We also extracted data on drugs known to affect urine stone risk profile if patients were on them during baseline and follow-up 24-hour urine collection: allopurinol, sodium bicarbonate, potassium citrate, thiazide and thiazide-like diuretics (indapamide, hydrochlorothiazide, chlorthalidone), and sodium-glucose cotransporter-2 inhibitors
Of course, those studies were performed in a type 2 diabetes population, which is characterized by a much higher risk of cardiovascular events as compared to the nondiabetic overweight or obese population that was studied in OASIS 1, he said
GHK-Cu's shorter evidence trail reflects investment gaps, not inferior biology
The current landscape: FDA-approved options in 2026 In 2026, the primary contenders for the title of best glp-1 for weight loss fall into two main categories: pure GLP-1 agonists and dual GLP-1/GIP agonists
Both mimic the activity of endogenous GLP-1, regulating blood glucose levels by increasing insulin secretion, inhibiting glucagon secretion, delaying gastric motility, and increasing feelings of satiety